BeSound Breast provides advanced, radiation-free ultrasound imaging for enhanced breast cancer detection, particularly effective for dense breast tissue. This technology offers a comfortable, 20-minute scan experience with AI-powered analysis and results delivered within 48 hours. The service aims to improve early detection rates, offering a modern alternative to traditional mammography.
Funding
$6.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
OVFounders
Product
Problem
Traditional mammography relies on ionizing radiation and breast compression, which can be uncomfortable and may miss cancers in dense breast tissue. Limited access to timely imaging and opaque pricing further hinder early detection for many women.
Solution
BeSound Breast offers an FDA‑approved, high‑resolution ultrasound platform that provides radiation‑free, compression‑free breast imaging. The system integrates AI algorithms to highlight suspicious lesions, delivering clinically reviewed results within 24–48 hours. Transparent, upfront pricing and a streamlined 20‑minute scan process improve patient experience and enable earlier intervention, especially for women with dense breasts or those under traditional screening age.
Target Audience
The primary customers are women seeking breast imaging—particularly those with dense breast tissue or under 40—and healthcare providers such as radiology clinics and primary‑care practices that require accurate, rapid, and patient‑friendly diagnostic tools.
Features
- Portable ultrasound device delivering high‑resolution volumetric breast images without ionizing radiation, compression, or contrast agents
- AI‑driven lesion detection pipeline that flags potential abnormalities for radiologist review
- Automated workflow producing diagnostic reports in 24–48 hours, accessible via a secure web portal
- Transparent, fixed pricing disclosed before appointment, eliminating surprise costs
- 20‑minute, pain‑free scan performed in a private room or mobile van, enhancing patient comfort and accessibility
- Integrated risk‑assessment questionnaire to personalize imaging protocols for each patient
- FDA‑cleared technology validated for improved cancer detection in dense breast tissue
- HIPAA‑compliant data handling and encrypted transmission to ensure patient privacy